MUC4 and posterior cortical atrophy: Superparamagnetic iron oxide nanoparticles can be targeted to identify PCACs, enhance magnetic resonance imaging of PCA,129 and inhibit MUC4‐mediated metastasis in PCA,130 thus playing a role in the treatment of PCA.